Locked predictions

initial lock — sentinel cascade: USA record bee colony losses 2024-2025 (55.6%) predict accelerated TFR decline by 2029-2030 via 5±2 year cross-species lag. Falsification: if USA TFR does NOT decline faster in 2029-2030 than 2024-2025 trend

An IVF laboratory with Faraday-cage EMF shielding will show significantly higher fertilization, blastocyst, and pregnancy rates compared to standard laboratories.

Long-term earbud users (>4h/day for >2 years) will show significantly lower heart rate variability (HRV) compared to matched non-users, indicating reduced vagal tone.

Male rats raised under LED lighting will show significantly lower sperm motility and concentration compared to rats raised under incandescent lighting, in a four-arm design separating light spectrum from EMF emission.

EU countries (mandatory LED transition 2009–2012 via Directive 244/2009 ↗iCommission Regulation (EC) No 244/20092009 · regulatoryMetadata matched) show faster TFR decline in 2015–2022 compared to countries with later or no incandescent ban, controlling for mobile density, GDP, and urbanization. Central estimate: TFR decline acceleration ≥0.02/year faster in EU vs non-EU controls.

A Faraday-shielded bedroom (< 0.001 V/m IF) with identical LED lighting produces better sleep quality than an unshielded bedroom, even when blue light spectrum is identical. This isolates the IF emission channel from the optical channel. If true: IF emissions (not blue light) are the primary sleep disruptor from LED lighting. If false: blue light or other factors dominate. Cost estimate: < EUR 5,000.

Low-level laser therapy (620–1100 nm) applied to testes in a controlled animal study will improve spermatogenesis markers (motility, concentration, morphology) via mitochondrial cytochrome c oxidase activation — the same chromophore mechanism as FDA-approved photobiomodulation devices. If LLLT (optical EM) improves fertility via CCO, and RF (lower EM) disrupts fertility via CRY, the chromophore generalization predicts that both optical and RF frequencies modulate reproductive biology through frequency-specific chromophore targets.

In a genotyped birth cohort with documented prenatal EMF exposure: stratify ASD/ADHD diagnosis rates by CACNA1C rs1006737 genotype AND maternal EMF exposure level. Prediction: significant GxE interaction where risk allele + high EMF produces synergistic elevation in ASD/ADHD rates beyond additive effects.

Expose hiPSC-derived neuronal cultures to EMF and measure network oscillation patterns (MEA). Then add lithium. Prediction: lithium restores oscillation regularity because it dampens Ca²⁺ oscillations via IMPA1/inositol pathway — the same mechanism that makes it effective in bipolar disorder.

Expose male mice to chronic RF-EMF. Mate with unexposed females. Analyze F1 male offspring sperm for DNA methylation patterns. Prediction: specific DMRs overlap with those in human radar study (Research Square 2025 ↗iGenome-wide sperm DNA methylation alterations in individuals exposed to radar electromagnetic radiationResearch Square (preprint) · 2025 · experimentalMetadata matched). If DMRs include CACNA1C or other VGCC genes, this closes the epigenetic feedback loop.

Replicate the GC-2 study across a wider intensity range (0.1, 0.5, 1, 2, 3, 5 mT). Prediction: methylation changes show non-monotonic dose-response with at least one sign reversal, paralleling Blackman’s Ca²⁺ window. If confirmed, Lindgren’s window dynamics operate at the epigenetic level.

Expose matched sperm samples to: (1) GSM-modulated 900 MHz (217 Hz TDMA), (2) LTE-modulated 900 MHz (OFDM), (3) CW 900 MHz, all at identical time-averaged SAR. Measure motility, ROS, DNA fragmentation. Prediction: GSM > LTE > CW because GSM’s hard pulse produces the strongest ELF membrane component. Directly tests Schwan + T-type bifurcation mechanism.

During lockdown, IF-sensitive diseases (infertility → improvement) and RF-sensitive diseases (depression → worsening) behave in opposite directions. The COVID lockdown acts as a natural experiment: workplace IF exposure dropped ~70% (offices with LED lighting closed) while home RF exposure rose ~40% (more phone/Wi-Fi usage). This predicts channel-specific, opposite-sign health effects.

In countries where the EU LED transition happened earlier, sperm quality decline should accelerate earlier than in countries where it happened later. EU vs non-EU difference-in-differences design, controlling for mobile density, GDP, and urbanization.

Seven chronic diseases' acceleration points follow the modulome's biological latency hierarchy: sleep < depression < ADHD < metabolic < autoimmune < infertility < cancer. Each acceleration point should fall 0–10 years after mass adoption of its specific technology generation.

Patients with higher baseline EMF exposure (measured by personal RF dosimetry) will show stronger acute response to psilocybin-assisted therapy, because chronic EMF-driven Ca²⁺ dysregulation creates a larger homeostatic deficit for the psychedelic Ca²⁺ reset to correct. High-EMF patients should show greater pre/post MADRS delta.

Patients carrying CACNA1C risk variants (associated with bipolar disorder and schizophrenia in GWAS) will show altered psilocybin response, because the psychedelic signal chain terminates at Cav1.2 (CACNA1C). Specifically, rs1006737 A-allele carriers should show either enhanced or paradoxical response to psilocybin, distinct from wild-type responders.

Lithium users will show attenuated mood deterioration in response to EMF exposure compared to non-lithium controls, because Li⁺ directly occupies VGSC and normalizes Na⁺/Ca²⁺ balance that EMF perturbs. Ecological test: lithium-treated bipolar patients should show no seasonal RF-correlated mood variation, while unmedicated patients should.

Controlled EMF exposure will measurably reduce skin TEP (baseline 10–60 mV) via Na⁺/K⁺-ATPase disruption. EHS-reporting individuals will show a larger TEP drop than matched controls under the same exposure, because their ion channel sensitivity threshold is lower. Double-blind measurement with Ag/AgCl electrodes on forearm skin.

Standardized skin wounds (e.g. suction blister) will heal significantly slower in high-EMF environments compared to Faraday-shielded controls, because exogenous EMF superimposes noise on the endogenous wound electric field (100–200 mV/mm) that guides keratinocyte electrotaxis. Effect size should correlate with EMF field strength.

Retinal damage attributed to LED blue light is partially caused by IF-EMF (65 kHz – 2 MHz) from the LED switching power supply, not blue light alone. An incandescent lamp filtered to identical blue spectrum (no IF-EMF) will produce significantly less retinal oxidative stress than LED blue light at the same intensity and spectrum.

IF-EMF exposure (65 kHz – 2 MHz, levels matching LED driver output) without any light stimulus will produce measurable oxidative stress in retinal cells via Cav1.4 VGCC activation. This would confirm that the IF-EMF component of LED light is independently biologically active on retinal tissue.

Phone/tablet 'night mode' (warm color filter) removes blue light but not IF-EMF from the display backlight. Melatonin suppression measured with night mode ON will be significantly greater than in a no-screen control, because IF-EMF continues to suppress melatonin via CRY pathway independent of light spectrum. Mechanistic basis: Chae et al. (2019) ↗iBlue light-dependent human magnetoreception in geomagnetic food orientationPLOS ONE · 2019 · journalMetadata matched demonstrated that human magnetoreception requires blue light (400–500 nm), identifying cryptochrome as the transducer. This implies two independent intervention points: (1) blue-light filtering removes CRY activation entirely (no radical pairs to disrupt), and (2) Faraday shielding removes RF disruption while preserving natural CRY function. BERM predicts Faraday shielding is more effective because it corrects the interference while leaving the natural system intact, whereas blue-light filtering removes the disruption by shutting down the entire CRY system.

The childhood myopia epidemic correlates with cumulative IF-EMF exposure (screen time + LED lighting hours) more strongly than with blue light dose alone. The EU incandescent ban (2009) provides a natural experiment: countries with faster LED adoption should show steeper myopia acceleration, controlling for education hours and outdoor time.

Hospitals with higher measured EMF levels (especially IF from LED lighting and RF from Wi-Fi density) will have higher post-hospital syndrome (PHS) incidence, controlling for patient acuity, length of stay, and standard care quality metrics. The correlation should be strongest in elderly patients (>75 years) who spend the most time bed-bound.

Patients in Faraday-shielded or low-EMF rooms (reduced Wi-Fi, incandescent/DC lighting, minimal monitors) will show faster recovery, shorter stays, lower delirium incidence, and better sleep quality compared to standard rooms, controlling for patient acuity and treatment protocols.

The observed advantage of home care over hospitalization for certain elderly patients is partially mediated by lower EMF exposure at home. Patients discharged to high-EMF home environments (multiple Wi-Fi networks, LED-heavy) will show outcomes closer to hospital patients than those in low-EMF homes.

Alzheimer's disease incidence correlates with cumulative lifetime EMF exposure (urban > suburban > rural), after controlling for education, cardiovascular risk, and ApoE4 status. The mechanism chain: EMF → VGCC → Ca²⁺ ↑ → BACE1 → Aβ oligomers → positive feedback loop. The calcium hypothesis (LaFerla, O'Day) identifies Ca²⁺ dysregulation as the proximal cause; BERM provides the upstream environmental driver.

CACNA1C rs7304986 T/C carriers (who show greater EMF sleep sensitivity per Sousouri 2025 ↗iCACNA1C genotype determines sleep EEG response to 5G exposure in double-blind studyNeuroImage · 2025 · journalMetadata matched) will have higher AD risk than T/T homozygotes in high-EMF environments but equivalent risk in low-EMF environments. This is the same gene × environment interaction as for EHS: genetically heightened VGCC sensitivity amplifies environmental Ca²⁺ dysregulation.

AD incidence in the 60–70 age group will accelerate beyond demographic aging predictions during 2025–2035, reflecting a ~30-year lag from mass 2G/Wi-Fi adoption (1995–2005). CAUTION: this acceleration could result from other causes (diabetes epidemic, sedentary lifestyle, diagnostic changes). The prediction is confirmable only if EMF-specific biomarkers (Ca²⁺ levels, VGCC expression) co-correlate.

AD patients in low-EMF care environments (Faraday-shielded or reduced Wi-Fi/LED) will show slower cognitive decline (MMSE/MoCA trajectory) than matched controls in standard care facilities. The Arendash paradox (controlled 918 MHz protects in mice) suggests dose/frequency/context matter — chaotic multi-frequency environmental EMF drives damage, while removal allows homeostatic recovery.

CACNA1C rs7304986 T/C-carrying mothers' prenatal EMF exposure will produce higher ADHD risk in offspring than T/T carriers'. This is a gene × environment interaction: genetically heightened VGCC sensitivity amplifies the developmental ion channel calibration error from prenatal EMF. The same CACNA1C variant associates with ADHD, ASD, bipolar, and EMF sleep sensitivity (Sousouri 2025 ↗iCACNA1C genotype determines sleep EEG response to 5G exposure in double-blind studyNeuroImage · 2025 · journalMetadata matched).

If ADHD is an ion channel calibration error, guanfacine (HCN channel modulator) should protect against EMF's ADHD-symptom-worsening effect better than stimulants (which only compensate by raising signal). In controlled EMF exposure, guanfacine-treated ADHD patients should show less symptom worsening than methylphenidate-treated patients, because guanfacine corrects the threshold while stimulants raise the signal.

ADHD prevalence acceleration follows prenatal EMF exposure growth with a 3–10 year lag (exposure → diagnosis age). 2G mass adoption 1991–95 → ADHD acceleration ~1995–2005. Smartphone mass adoption 2007–12 → ADHD acceleration ~2012–2020. 5G mass adoption 2019–24 → ADHD acceleration ~2025–2035 (prediction). CAUTION: ADHD diagnostic practices have changed significantly — prevalence data requires careful correction for diagnostic trends.

Bipolar patients in higher-EMF environments should have more frequent mood cycles, because stronger ionic perturbation destabilizes the neural oscillator — amplitude increases and period shortens. Computational models (PubMed 32278494iIon channel conductance changes underlie bipolar neuron excitability oscillationsTranslational Psychiatry · 2020 · journalVerification pending) show bipolar neurons oscillate between hyperexcitability and hypoexcitability due to ion conductance changes; EMF adds external perturbation to this unstable system.

Lithium-treated bipolar patients will benefit from EMF shielding (Faraday) because Li⁺ dampens the oscillation AND EMF removal eliminates the perturbation — combined effect exceeds either alone. Li⁺ traverses VGSC and accumulates in hyperactive neurons; removing the EMF perturbation source reduces the oscillation that lithium must dampen.

IVF laboratories with higher ambient EMF will have lower fertilization rates, blastocyst development, and clinical pregnancy rates. Melatonin in follicular fluid is a critical oocyte protectant (Tamura 2012 ↗iThe role of melatonin as an antioxidant in the follicleJournal of Ovarian Research · 2012 · journalMetadata matched); EMF suppresses endogenous melatonin (Battelle 1980iChronic exposure to 60-Hz electric fields: effects on pineal function in the ratBioelectromagnetics · 1980 · journalVerification pending, circadian pathway), reducing follicular antioxidant defense during the most vulnerable phase. Tong 2017 ↗iMelatonin levels in follicular fluid as markers for IVF outcomes and predicting ovarian reserveReproduction · 2017 · journalMetadata matched meta-analysis already shows melatonin supplementation improves IVF outcomes — the prediction is that EMF environment is a confound in existing IVF data.

Melatonin supplementation benefit in IVF will be LARGER for patients in high-EMF environments, because high EMF creates a deeper melatonin deficit that supplementation partially corrects. In low-EMF environments, endogenous melatonin is already near-optimal, so exogenous supplementation adds less. This predicts an interaction term (melatonin × EMF) in IVF outcome regression, not just a melatonin main effect.

Shift workers have suppressed nocturnal melatonin (circadian disruption + workplace lighting + occupational EMF), predicting lower natural fertility AND a larger absolute benefit from melatonin supplementation compared to day workers. The melatonin bridge connects cascade 1 (sleep/circadian) to cascade 6 (fertility) — shift work is the strongest natural experiment for this connection because it disrupts melatonin through multiple converging pathways simultaneously.

LED driver switching frequencies (20–100 kHz) overlap the normal-cell mitotic disruption range identified by TTFields research (Neuhaus et al., Nature 2020: normal cells most affected at ~50 kHz, vs. cancer cells at 150–200 kHz). Prediction: in vitro exposure of normal dividing cells (e.g. spermatogonia, intestinal crypt cells) to 20–100 kHz pulsed fields at LED-driver-representative intensities will produce measurable increases in aneuploidy, mitotic spindle misalignment, or reduced proliferation rate. The Kaiser Permanente series (Li 2002–2020) provides epidemiological support: EMDEX-measured MF exposure associates with miscarriage, sperm quality decline, and childhood conditions across 6 cohorts.

RCT: B2 supplementation (25mg/day x 8 weeks) vs placebo in subjects with poor sleep quality and high nighttime phone use. Primary endpoint: melatonin onset latency. Secondary: sleep efficiency, cortisol awakening response. B2 group should show less circadian disruption because FAD-replete CRY is more stable against EMF perturbation. Mechanistic basis: Hirano 2017 ↗iFAD Regulates CRYPTOCHROME Protein Stability and Circadian Clock in MiceCell Reports · 2017 · journalMetadata matched (FAD -> CRY stability), Iversen 2025 ↗iMagnetically Stimulated Myogenesis Recruits a CRY2-TRPC1 Photosensitive Signaling AxisCells 14(3):231 · 2025 · journalMetadata matched (FAD -> magnetic sensitivity).

Add population-level B2 adequacy as a control variable to the 54-country EMF-TFR regression model. Prediction: the interaction term (EMF x B2_deficiency) is significant and negative — countries with BOTH high EMF AND high B2 deficiency show steeper TFR decline than countries with high EMF alone. China (>90% B2 deficiency, highest EMF, lowest TFR) vs. Finland (~15% B2 deficiency, high EMF, higher TFR) is the key contrast. CAUTION: This is ecological evidence — correlation, not causation. This applies equally to conventional explanations.

Replicate Chae 2019 ↗iBlue light-dependent human magnetoreception in geomagnetic food orientationPLOS ONE · 2019 · journalMetadata matched food orientation paradigm with graded fasting durations (4h, 8h, 12h, 16h, 24h). Prediction: inverted U-shaped dose-response — sensitivity peaks at 12-16h (optimal CRY turnover with adequate FAD) and declines at 24h+ (FAD pool depletion begins). Additional arm: B2-supplemented (25mg pre-fast) vs. unsupplemented subjects. B2 supplementation should right-shift the peak (allowing longer fasting before decline). The fasting paradox resolution (Lamia 2009 ↗iAMPK Regulates the Circadian Clock by Cryptochrome Phosphorylation and DegradationScience · 2009 · journalMetadata matched AMPK-CRY + beta-oxidation FAD) predicts this specific shape.

In a declared reproductive-cell system, cross field/sham with no intervention, L-type blockade, TRPC1 perturbation and both. Measure the first calcium/current response, ER-store change, repair and reproductive function at separate times; add genetic rescue or a downstream bypass. Compare (field−sham) between intervention states on a prespecified scale. A residual after nifedipine is not automatically TRPC1-mediated because other VGCC subtypes and pathways remain. The prediction is a reproducible intervention-dependent field contrast, not predetermined pathway percentages.

Pituitary gonadotrophs express Cav3 T-type channels for hormone secretion. EMF perturbation of these channels reduces FSH/LH pulsatility independently of hypothalamic GnRH. Test: expose pituitary cell cultures to standardized EMF with and without T-type channel blocker (ethosuximide). Prediction: EMF reduces FSH/LH secretion; ethosuximide abolishes the effect.

Aged mitochondria produce more ROS per unit Ca2+ influx than young mitochondria. Test: expose testicular tissue from young (3-month) and old (18-month) rats to identical EMF. Measure mitochondrial ROS production. Prediction: old tissue produces disproportionately more ROS per unit EMF exposure, following the v18_mitochondrial_ros_amplifier() function.

Riboflavin (B2) is the precursor for FAD, which is required by both glutathione reductase (GR, redox defense) and cryptochrome (CRY, EMF sensor). B2 supplementation should simultaneously: (a) increase effective glutathione buffering capacity (via GR), and (b) stabilize CRY against EMF perturbation (via FAD loading). Test: B2-supplemented vs. unsupplemented cell cultures under EMF. Measure both GSH/GSSG ratio and CRY-dependent circadian gene expression.

Heart rate variability (HRV), specifically the high-frequency (HF) component reflecting vagal tone, decreases with chronic EMF exposure before clinical symptoms appear. The SA node's Cav3.1 T-type channels are the transducer. Test: correlate personal RF dosimetry with 24-hour HRV monitoring in a cohort (N=200). Prediction: inverse dose-response between cumulative EMF and HF-HRV, independent of age, fitness, and stress.

The placental barrier uses the same tight junction (TJ) proteins as BBB and BTB (occludin, ZO-1, claudins). EMF exposure during pregnancy should decrease placental TJ protein expression in a dose-dependent manner. Test: measure placental TJ protein levels in women with high vs. low EMF exposure during pregnancy (personal dosimetry). Prediction: higher EMF exposure correlates with lower occludin and ZO-1 expression.

Thyroid cells express VGCCs and are sensitive to EMF-induced Ca2+ disruption. National thyroid dysfunction prevalence (hypothyroidism, elevated TSH) should correlate with mobile phone adoption rate, controlling for iodine status, age structure, and diagnostic practices. This is an ecological prediction — correlation, not causation. This applies equally to conventional explanations.

Retrospective case-control study: compare baby monitor type (DECT vs. WiFi vs. wired vs. none) and placement distance (< 0.5 m, 0.5–1 m, > 1 m) between SIDS cases and age-matched controls. DECT monitors at < 0.5 m produce 2.5–3.5 V/m continuous RF through a 2 mm infant skull. Prediction: DECT or WiFi monitor placement within 0.5 m of the crib is more common in SIDS cases than controls, after controlling for known risk factors.

Post-mortem genotyping of SIDS victims for CACNA1C rs1006737 (the BERM risk allele). The AA genotype increases Cav1.2 expression and is associated with psychiatric and cardiac risk in adults. In infants with immature Ca²⁺ homeostasis, this gain-of-function variant should increase vulnerability to any Ca²⁺-disrupting stressor. Prediction: AA genotype frequency in SIDS victims exceeds population baseline.

Measure maternal light and local fields, the timing and concentration of milk melatonin, and a named infant circadian endpoint. Night-milk melatonin is a time signal with tissue-dependent receptor effects, not a universal Ca²⁺ antagonist. An EMF-related change and its infant functional consequence require separate contrasts; the rat MT2 cell result supplies no infant dose coefficient.

Measure maternal light and local fields, the timing and concentration of milk melatonin, and a named infant circadian endpoint. Night-milk melatonin is a time signal with tissue-dependent receptor effects, not a universal Ca²⁺ antagonist. An EMF-related change and its infant functional consequence require separate contrasts; the rat MT2 cell result supplies no infant dose coefficient.

Interventional study in NICU: compare apnea and bradycardia episode frequency in preterm infants in standard NICU environment vs. EMF-minimized environment (wired monitors, no WiFi, RF-shielded incubator, amber lighting). Prediction: EMF-minimized NICU environment reduces apnea/bradycardia episodes, with larger effect in infants with known ion channel variants.

Pharmacogenetic analysis: genotype ADORA1 and ADORA2A receptor polymorphisms in SIDS victims (post-mortem) and in preterm infants receiving caffeine therapy. The same adenosine receptor variants that modulate caffeine response in apnea of prematurity should predict SIDS susceptibility, because both conditions involve adenosine-Ca²⁺ pathway disruption in the respiratory center. Prediction: ADORA variants that predict poor caffeine response are overrepresented in SIDS victims.

If the resonance model is correct, SIDS risk should correlate with Q_neonatal(age) = Q₀/(1+(age/τ_KCC2)²) better than with age alone. The Q-factor declines as KCC2 matures and GABA transitions from excitatory to inhibitory. Test: fit SIDS incidence-by-age curves to Q_neonatal(age) vs. linear/quadratic age models. Prediction: Q-factor model fits SIDS age distribution better (lower AIC) than purely age-based models.

Bumetanide blocks NKCC1, restoring inhibitory GABA and introducing damping (reducing Q). If SIDS results from resonance failure in an undamped system, bumetanide should reduce apnea and bradycardia episodes in high-risk neonates (those with ion channel variants or prior apparent life-threatening events). Test: randomized trial of low-dose bumetanide in NICU infants with recurrent apnea. Prediction: bumetanide reduces apnea/bradycardia episode frequency.

An undamped resonator (Q→∞) concentrates energy at its natural frequency. Neonatal EEG in high-risk infants should show narrower spectral peaks and higher inter-channel coherence in delta/theta bands compared to low-risk controls. This spectral signature should diminish as KCC2 matures (3–6 months). Test: serial EEG in SIDS-risk vs. control infants from birth to 6 months. Prediction: high-risk infants show elevated spectral coherence that normalizes on the KCC2 maturation timeline.

The three-protections model predicts that cultures practicing co-sleeping (no monitor), breastfeeding (>90%), and continuous skin contact should maintain low SIDS rates regardless of ambient EMF level. Test: compare SIDS rates across cultures stratified by (1) ambient EMF density and (2) co-sleeping/breastfeeding/skin-contact practices. Prediction: SIDS rate correlates with monitor use and formula feeding, not with ambient EMF density, after controlling for the three protections.

If the resonance model is correct, SIDS victims should have higher NKCC1/KCC2 ratios (less mature chloride transporter switch → higher Q → more excitatory GABA) compared to age-matched infants who died of non-SIDS causes. Test: immunohistochemistry for NKCC1 and KCC2 in brainstem tissue from SIDS vs. non-SIDS infant post-mortem samples. Prediction: SIDS victims show elevated NKCC1/KCC2 ratio compared to age-matched controls.

The resonance spectrum model predicts a continuous dose-response relationship between prenatal/neonatal EMF exposure and neurodevelopmental outcomes: highest exposure → SIDS risk, moderate → developmental delay, low → subtle motor/cognitive differences. Test: prospective birth cohort with personal EMF dosimetry (phone use, WiFi proximity, monitor use) followed to 36 months with standardized developmental assessment. Prediction: EMF exposure shows graded dose-response with developmental outcomes, with fine motor (OR ≥ 2.5) and problem-solving (OR ≥ 3.0) most affected, consistent with the prospective cohort finding (OR 2.74 fine motor, OR 3.67 problem-solving).

The Q-factor model predicts that chronic migraine prevalence should increase with cumulative EMF exposure (ELF-priming → α2δ-1↑ → CSD threshold↓). Test: correlate chronic migraine prevalence trends (1990→2025) with cumulative EMF technology adoption (mobile, WiFi, LED) across countries. Prediction: countries with earlier and denser EMF adoption show steeper migraine prevalence increase.

ELF exposure upregulates α2δ-1 (CACNA2D1), increasing VGCC density at synapses and lowering CSD threshold. Gabapentin blocks α2δ-1 trafficking. Test: expose cortical slices to chronic ELF (50 Hz, 7 days), then measure CSD threshold (KCl concentration needed to trigger CSD). Repeat with gabapentin co-treatment. Prediction: ELF lowers CSD threshold; gabapentin co-treatment normalizes it.

The cluster headache patient profile (male 3:1, smoker 60–90%, onset ~30 years, attacks 00–03) maps onto a cumulative Ca²⁺-loading profile. EMF exposure history (occupational, residential) should be higher in cluster headache patients than matched controls. Test: case-control study with detailed EMF exposure assessment (occupation, residential proximity to infrastructure, device use). Prediction: cluster headache patients have statistically higher lifetime EMF exposure.

SUDEP shares the same spreading depolarization → brainstem mechanism as SIDS. If EMF contributes to CSD propagation, SUDEP incidence should be higher in high-EMF environments (urban) compared to low-EMF environments (rural), after controlling for seizure frequency and medication compliance. Test: registry study comparing SUDEP incidence in urban vs. rural epilepsy patients. Prediction: urban epilepsy patients have higher SUDEP rate after controlling for seizure frequency.

Psilocybin resets the tryptamine pathway (5-HT2A → thalamo-cortical reset → SCN circadian reset). If ongoing EMF exposure re-primes α2δ-1 and disrupts the SCN after reset, psilocybin efficacy should be greater when combined with EMF reduction. Test: RCT of psilocybin + EMF reduction protocol vs. psilocybin alone in episodic cluster headache. Prediction: combined intervention produces longer remission than psilocybin alone.

López-Martín showed GSM + picrotoxin (GABA antagonist) = seizures, while neither alone sufficed. The neonatal brain has endogenously excitatory GABA (NKCC1>KCC2), equivalent to pharmacological GABAergic reduction. Test: expose neonatal rodents (P3–P7, before KCC2 switch) to pulsed GSM 900 MHz at mobile-phone intensity without picrotoxin. Prediction: neonatal animals show seizure activity or epileptiform EEG changes without pharmacological pre-treatment, while adult animals do not.

Heavy metals (Cd²⁺, Pb²⁺) enter cells through EMF-opened VGCCs and mimic Ca²⁺ at calmodulin/CaMKII binding sites. Chelation removes metals; EMF reduction closes the entry pathway. Combined intervention should be superadditive. Test: RCT of chelation + EMF reduction vs. chelation alone vs. EMF reduction alone in EHS patients with elevated heavy metal levels. Prediction: combined group shows >50% improvement vs. <25% for either alone.

Pineal gland calcification (PGC) reduces melatonin production (r=0.569 for uncalcified tissue↔melatonin). EMF accelerates PGC via oxidative stress and Ca²⁺ deposition. Test: cross-sectional study correlating PGC volume (CT/MRI) with occupational EMF exposure history. Prediction: high-EMF occupations (electricians, telecom workers) have significantly higher PGC volume than matched low-EMF controls.

Cd²⁺ permeates through Cav3.1 T-type calcium channels (confirmed with radiolabeled ¹⁰⁹Cd²⁺). Cav3.1 has a window current near resting potential — EMF increases open probability → more Cd entry. Test: compare tissue Cd levels in workers with equal dietary/occupational Cd exposure but different EMF exposure. Prediction: high-EMF group has higher tissue Cd accumulation at equivalent external Cd levels.

Methylmercury increases T-type Ca²⁺ currents; EMF independently opens VGCCs. Combined effect: double Ca²⁺ loading. Populations with both high MeHg (fish diet) and high EMF (urban) should show neurotoxicity at lower MeHg levels than high-MeHg + low-EMF populations. Test: compare neurodevelopmental outcomes in Faroe Islands (high MeHg, low EMF) vs. urban Japan (high MeHg, high EMF) at equivalent MeHg exposure. Prediction: urban Japan shows effects at lower MeHg thresholds.

The VGCC hypothesis predicts that blocking the Ca²⁺ channel should prevent ALL downstream EMF effects. Sousouri 2025 ↗iCACNA1C genotype determines sleep EEG response to 5G exposure in double-blind studyNeuroImage · 2025 · journalMetadata matched showed CACNA1C genotype determines 5G sleep response. Test: ETH Zürich nimodipine-5G follow-up — administer nimodipine (L-type Ca²⁺ blocker) before 5G exposure and measure sleep EEG. Prediction: nimodipine abolishes the genotype-dependent sleep EEG changes seen in the original study.

Amish communities have minimal EMF exposure (no grid electricity, no wireless devices), high co-sleeping, high breastfeeding. If EMF is a significant driver of chronic disease trends, Amish should show divergent trajectories for BERM-predicted conditions. Test: compare age-adjusted incidence trends (1990→2025) for T2D, obesity, autism, ADHD, depression, myopia, SIDS in Amish vs. general US population. Prediction: Amish show stable or declining rates where the general population shows increase.

This is BERM's critical missing piece: interventional verification. All current evidence is observational or mechanistic. Test: RCT of comprehensive EMF reduction (shielded sleeping environment, wired devices, no LED at night) in symptomatic individuals for 3 months. Measure: CaMKII Thr286 phosphorylation in lymphocytes, sleep quality (actigraphy), melatonin (urine 6-sulfatoxymelatonin), blood pressure. Prediction: EMF reduction group shows significant improvement in all four biomarkers.

Feedback loop 4 predicts a cascading cycle: EMF suppresses melatonin → sleep deteriorates → GABA tonic inhibition decreases → Q-factor increases → brain becomes MORE sensitive to EMF → further melatonin suppression. Test: longitudinal study measuring evening EMF exposure, overnight melatonin (saliva), sleep quality (PSG), morning GABA (MRS spectroscopy), and EEG coherence (Q proxy) over 4 weeks. Prediction: initial EMF exposure produces self-amplifying deterioration across all measures.

RF-EMF (27.12 MHz) increases BBB permeability via eNOS↑ and occludin↓. Melatonin protects tight junction proteins (occludin, claudin-5, ZO-1). Test: measure BBB permeability (gadolinium-enhanced MRI) during RF exposure with and without melatonin pre-treatment. Prediction: melatonin pre-treatment prevents EMF-induced BBB opening.

EMF opens BBB → heavy metals (Pb, Cd, MeHg) enter brain more easily. EMF also suppresses melatonin → BBB protection↓ → DOUBLE vulnerability. Test: compare brain heavy metal accumulation (post-mortem or CSF) between high-EMF occupations and matched low-EMF controls with equivalent peripheral heavy metal levels. Prediction: high-EMF group has higher brain metal levels at equivalent blood levels.

5G (3.5 GHz) → PRDM16 mRNA↓ + C/EBPβ mRNA↓ in brown adipose tissue. BAT uses Ca²⁺ cycling (SERCA) for energy expenditure. Test: expose rodents to 5G and measure BAT PRDM16 protein, thermogenic capacity (cold challenge), and energy expenditure. Prediction: 5G-exposed animals show reduced cold-induced thermogenesis and weight gain on identical caloric intake.

EMF sets a new HPA axis setpoint with sensitization rather than adaptation. Chronic exposure → sustained cortisol elevation + adrenal hypertrophy. Test: measure hair cortisol (3-month integrated cortisol) in telecom workers vs matched office workers. Prediction: telecom workers show significantly higher hair cortisol after controlling for perceived stress and lifestyle factors.

Animal studies show EMF → ACTH↑ + corticosterone↑ + adrenal hypertrophy. This anatomical change should be detectable in chronically exposed humans. Test: compare adrenal gland volume (CT/MRI) in workers with >10 years high-EMF exposure vs matched controls. Prediction: high-EMF group has significantly larger adrenal glands.

Electric fields can induce insulin secretion WITHOUT glucose. ELF-EMF alters glucose-stimulated insulin dynamics. CaVγ4→CaMKII→MafA pathway: CaMKII dysregulation → β-cell maturity loss. Test: measure insulin secretion dynamics (first-phase insulin response) in EMF-exposed vs control subjects during OGTT. Prediction: EMF-exposed group shows blunted first-phase insulin with elevated basal insulin.

Verapamil (L-type Ca²⁺ blocker) protects β-cells and improves T1D outcomes (JAMA 2023 ↗iEffect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 DiabetesJAMA · 2023Metadata matched). If EMF damages β-cells via Ca²⁺ channels, verapamil should also prevent EMF-induced β-cell dysfunction. Test: expose β-cell cultures to EMF with/without verapamil; measure insulin secretion and MafA expression. Prediction: verapamil prevents EMF-induced insulin secretion changes and MafA↓.

835 MHz (12 weeks) reduces synaptic vesicle number, size, and docking in hypothalamus, plus synapsin I/II↓ and synaptotagmin 1↓. Synaptotagmin 1 is the Ca²⁺ sensor for vesicle release. Its loss means ALL hypothalamic hormone release is impaired. Test: replicate Kim 2019 ↗iTrafficking of synaptic vesicles is changed at the hypothalamus by exposure to an 835 MHz radiofrequency electromagnetic fieldGeneral Physiology and Biophysics · 2019Metadata matched with additional hormone panel (GnRH, CRH, TRH, GHRH, dopamine). Prediction: multi-hormone deficit pattern matching BERM predictions.

If EMF disrupts hypothalamic synaptic transmission broadly (VK13), ALL hormone axes should be affected simultaneously. The triple lock (T↓ × cortisol↑ × DA↓) should be accompanied by GH↓ and thyroid changes. Test: measure full hormone panel (T, LH, cortisol, ACTH, GH, IGF-1, TSH, fT4, dopamine) in chronic EMF-exposed vs controls. Prediction: coherent multi-axis disruption pattern.

Ca²⁺ is the primary trigger for mast cell degranulation. EMF → VGCC → Ca²⁺ → mast cell releases histamine + IL-1β + tryptase. Johansson 2000iIncomplete referenceVerification pending showed mast cell changes in skin biopsies after display terminal exposure. Test: measure serum tryptase (specific mast cell degranulation marker) before and after standardized EMF exposure. Prediction: acute EMF exposure produces measurable tryptase elevation.

If EMF symptoms are partly mediated by mast cell degranulation, mast cell stabilizers (cromolyn sodium, ketotifen) should prevent them. Test: RCT of cromolyn + EMF exposure vs placebo + EMF exposure in EHS patients. Measure: skin reactions, systemic symptoms, serum histamine/tryptase. Prediction: cromolyn group shows significantly fewer symptoms and lower histamine/tryptase.

Environmental disruptions (stress, inflammation) delay KCC2 maturation → GABA stays excitatory longer → Q-factor elevated longer → wider vulnerability window. IL-1β (from mast cells or glia) → KCC2↓. ROS → KCC2↓. EMF → both ROS and IL-1β. Test: expose pregnant rodents to EMF; measure KCC2/NKCC1 ratio in offspring hippocampus at P7, P14, P21. Prediction: EMF-exposed offspring show delayed KCC2 switch.

The triple lock theory predicts that EMF simultaneously reduces testosterone (HPG), elevates cortisol (HPA), and reduces dopamine (mesolimbic). Each has been verified independently; the prediction is that they co-occur in the SAME individuals proportional to EMF exposure. Test: measure T, cortisol, and urinary HVA (dopamine metabolite) in high vs low EMF occupations. Prediction: triple deficit pattern (T↓ + cortisol↑ + HVA↓) correlates with cumulative EMF exposure.

EMF → cortisol↑ → hippocampal dendritic retraction + neurogenesis↓ → volume loss. Hippocampus is also the HPA negative feedback center — its damage removes cortisol braking → cortisol↑↑ (feedback loop S9). Test: compare hippocampal volume (MRI volumetry) in workers with >10 years high-EMF exposure vs matched controls, controlling for age, stress, depression. Prediction: high-EMF group shows reduced hippocampal volume.

If EMF → PRDM16↓ → BAT↓ → thermogenesis↓ → weight gain, then EMF reduction should restore BAT function. Test: measure supraclavicular BAT activity (infrared thermography after cold challenge) before and after 3-month EMF reduction protocol. Prediction: EMF reduction group shows increased BAT thermogenesis and modest weight loss without dietary change.

CatSper channels in sperm activate prematurely under RF-EMF, causing energy depletion before reaching the egg (‘premature energy expenditure’). Test: dose-response study of CatSper activation vs SAR level in human sperm samples. Prediction: CatSper activation increases with SAR; sperm exposed to mobile-phone-level RF show premature hyperactivation and reduced fertilization capacity.

Cortisol↑ → GnIH↑ → GnRH↓ → T↓ is a verified cross-suppression pathway. RF9 (GnIH antagonist) restored T in cortisol-treated primates. Test: expose rodents to chronic EMF with/without RF9-type GnIH antagonist. Prediction: GnIH antagonist prevents EMF-induced T decline, confirming HPA-HPG cross-suppression as the mechanism.

Cav1.2 is essential for OPC differentiation and myelination. SMF increases Cav1.2 in OPCs. Chronic RF may dysregulate Cav1.2 in developing brain → myelination timing disruption → white matter integrity↓. Test: expose developing rodent brains to chronic RF; measure Cav1.2 expression in OPCs and myelination markers (MBP, PLP) at developmental timepoints. Prediction: RF-exposed animals show altered myelination timing.

TTFields (200 kHz) increase NK cytotoxicity while 50 Hz ELF suppresses it — direct validation of BERM’s frequency-dependent pathway hierarchy. Test: compare NK cell cytotoxicity across ELF (50 Hz), RF (900 MHz, 2.4 GHz), and IF (200 kHz) exposures. Prediction: IF range shows NK activation while ELF and RF show suppression — different frequencies, different biological outcomes via the same VGCC mechanism.

Per2 knockout disrupts gut barrier → LPS enters bloodstream → neuroinflammation → depression. EMF disrupts circadian rhythm → Per2↓. Test: measure Per2 expression in gut epithelial biopsies of shift workers (circadian disruption proxy) vs day workers, correlated with EMF exposure history and serum LPS levels. Prediction: EMF/circadian disruption → Per2↓ → elevated serum LPS.

5h sleep → T -10-15% (JAMA 2011 ↗iEffect of 1 Week of Sleep Restriction on Testosterone Levels in Young Healthy MenJAMA · 2011 · journalMetadata matched). EMF → T↓ via three routes (VK13, VK15, VK22). Combined sleep restriction + EMF should produce GREATER T decline than either alone (superadditive). Test: 2×2 factorial RCT: normal sleep/restricted sleep × low EMF/high EMF. Measure T at baseline and after 1 week. Prediction: interaction term is significant — combined group shows >25% T decline vs ~15% for sleep alone.

RF 835 MHz (postnatal) reduces BDNF in CA1 and dentate gyrus with dendritic spine loss and memory impairment (PMC8159076 ↗iExposure to RF-EMF Alters Postsynaptic Structure and Hinders Neurite Outgrowth in Developing Hippocampal Neurons of Early Postnatal MiceInternational Journal of Molecular Sciences · 2021Metadata matched). Meanwhile ELF increases BDNF (hormesis). Test: measure serum BDNF in children stratified by personal RF exposure (phone use, WiFi proximity). Prediction: higher RF exposure correlates with lower BDNF and poorer spatial memory scores.

EMF → melatonin↓ → Per2↓ in gut → barrier disruption → LPS enters bloodstream → systemic inflammation. Gut barrier uses the SAME tight junction proteins as BBB (ZO-1, occludin, claudins), and melatonin protects both. Test: measure serum LPS-binding protein and zonulin (gut permeability markers) in high-EMF vs low-EMF occupation workers. Prediction: high-EMF group has elevated gut permeability markers.

EMF reduces hypothalamic Dio2/Dio3 → T4→T3 conversion is inhibited → blood T4 appears 'normal' but tissues don't receive T3. Test: measure FT3/FT4 ratio in high-EMF occupations (telecom, electricians) vs matched low-EMF controls. Prediction: high-EMF group has significantly lower FT3/FT4 ratio despite normal TSH and T4.

EMF alters sperm epigenome dose-dependently (1 mT: methylation↓, 3 mT: methylation↑). If EMF effects follow the DDT transgenerational model, methylation changes should persist to F3. Test: expose F0 rodents to chronic EMF; analyze sperm methylation profiles in F1, F2, F3. Prediction: F3 sperm methylation retains EMF-signature from F0 exposure. BERM's HIGHEST PRIORITY research proposal.

EMF→ROS↑ + melatonin↓→telomerase↓ + SIRT1↓ should accelerate telomere shortening. Test: measure leukocyte telomere length in occupational EMF cohort stratified by exposure years. Control for age, smoking, BMI. Prediction: cumulative EMF exposure correlates with shorter telomeres after controlling for confounders.

Melatonin activates telomerase + SIRT1 (anti-aging). EMF→melatonin↓ removes this protection. Test: RCT of melatonin supplementation (3-5 mg/night, 12 months) in high-EMF workers. Measure telomere length at baseline and 12 months. Prediction: melatonin group shows significantly less telomere shortening than placebo.

Oxytocin release is directly VGCC-dependent (N-type + L-type Ca²⁺ channels). EMF disrupts VGCC → OXT release disrupted. Test: measure salivary or plasma oxytocin in controlled EMF exposure study (pre/post acute exposure). Prediction: acute EMF exposure reduces oxytocin response to social stimuli.

ELF-priming (VK4) upregulates VGCC expression including α2δ-1 subunits. α2δ-1 overexpression alone produces neuropathic pain behavior WITHOUT nerve injury. Test: expose rodents to chronic ELF (50 Hz, 8-10 days); measure α2δ-1 expression in DRG and spinal dorsal horn. Prediction: ELF produces α2δ-1 upregulation and pain-like behavior without nerve damage.

NKCC1/KCC2 ratio is elevated in ASD (GABA stays excitatory). EMF disrupts KCC2 maturation via IL-1β (S9) and ROS. Test: measure plasma NKCC1/KCC2 ratio in ASD children; correlate with maternal prenatal EMF exposure history (occupation, device use, residential proximity to base stations). Prediction: higher prenatal EMF correlates with higher NKCC1/KCC2 ratio in ASD cases.

Bumetanide blocks NKCC1 → restores inhibitory GABA. EMF reduction removes the upstream driver of KCC2↓. Together they should be superadditive. Test: 2×2 RCT in ASD children: bumetanide/placebo × EMF reduction/standard. Measure CARS score, SRS, sensory sensitivity. Prediction: combined group shows significantly better improvement than either intervention alone.

ADHD shows 5-year PFC maturation delay (Shaw 2007 PNASiIncomplete referenceNo verified source link). EMF disrupts OPC myelination via Cav1.2 (VK20) and reduces DA in PFC. Test: DTI white matter integrity in PFC of ADHD children correlated with prenatal/neonatal EMF exposure history. Prediction: higher prenatal EMF correlates with delayed PFC myelination markers.

Motor neurons have low Ca²⁺ buffering + Ca²⁺-permeable AMPA receptors making them selectively vulnerable to Ca²⁺ overload. Multiple meta-analyses show OR 1.3-1.7 for electrical workers. Test: pooled analysis of existing occupational cohorts controlling for confounders. Prediction: EMF exposure is an independent ALS risk factor (OR > 1.2).

90%+ of serotonin is produced in gut enterochromaffin cells. EMF→circadian disruption→Per2↓→gut barrier↓ (S14) should alter microbiome. Test: 16S rRNA sequencing of gut microbiome in EMF-exposed vs controls. Prediction: EMF exposure shifts microbiome composition, specifically reducing 5-HT-producing species (Lactobacillus, Bifidobacterium).

Mast cell degranulation is Ca²⁺-dependent. EMF→VGCC→Ca²⁺ should lower the activation threshold. Test: in vitro mast cell degranulation assay comparing cells from EMF-exposed vs control subjects, measuring histamine release threshold. Prediction: mast cells from EMF-exposed individuals degranulate at lower stimulation thresholds.

Vitamin D (1,25(OH)₂D₃) downregulates CACNA1C/1D mRNA (J Neurosci 2001 ↗iVitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neuronsThe Journal of Neuroscience · 2001Metadata matched). Vitamin D deficiency → VGCC over-expression = same state as ELF-priming (VK4). Test: measure VGCC expression in PBMCs before/after vitamin D supplementation in deficient individuals. Prediction: vitamin D repletion reduces VGCC protein expression.

Low vitamin D → VGCC over-expressed → more Ca²⁺ per EMF photon = higher EMF sensitivity. Test: correlate vitamin D status with EMF-induced biomarker changes (CaMKII Thr286, sleep EEG) in controlled exposure study. Prediction: vitamin D-deficient individuals show larger EMF-induced biomarker changes.

PEMF promotes bone growth at specific parameters while some chronic-EMF studies report harm. BERM proposes a Ca²⁺-channel hormesis explanation. Test: measure Ca²⁺ signaling in osteoblasts across PEMF frequency, intensity and duration. Prediction: optimal parameters correspond to a peak in the endpoint response. The bounded χ_geo coordinate and a conditional response-operator form follow from the stated geometric and coupling assumptions, but the osteoblast tissue kernel, sign and dose-response remain uncalibrated.

Triple hit: CACNA1C risk variant (genetic) + vitamin D deficiency (→VGCC↑) + EMF exposure (→Ca²⁺↑) should produce highest schizophrenia risk. Test: genotype CACNA1C + measure vitamin D + estimate EMF exposure in schizophrenia case-control study. Prediction: three-way interaction is significant — triple-hit individuals have highest odds ratio.

CatSper is temperature-gated (threshold 33.5°C, Q₁₀=5.1). EMF→Ca²⁺ could lower the thermal activation threshold. Test: measure CatSper activation temperature in sperm from men with different occupational EMF exposure levels. Prediction: higher EMF exposure correlates with lower CatSper activation threshold.

Psilocybin promotes dendritic spine growth via 5-HT2A→Ca²⁺→BDNF→mTOR (VK52). EMF→cortisol→hippocampal dendritic atrophy (VK14). Test: chronic EMF exposure → dendritic loss, then single psilocybin dose → measure dendritic recovery. Prediction: psilocybin reverses EMF-induced hippocampal dendritic loss.

Caffeine blocks A2A receptors → reduces neuroinflammation → Ca²⁺ modulation. Regular caffeine consumers should show attenuated EMF biomarker responses. Test: controlled EMF exposure, stratify by caffeine consumption. Prediction: habitual caffeine consumers show smaller CaMKII Thr286 and sleep EEG changes from EMF.

Lithium modulates GSK-3β and CaMKII — key nodes in the BERM Ca²⁺ cascade. Areas with higher natural lithium in drinking water should show attenuated EMF health effects. Test: correlate drinking water lithium with EMF-associated disease incidence (dementia, suicide, depression) at county level. Prediction: interaction term (lithium × EMF) is significant and protective.

EMF→cortisol↑ (VK11) → amygdala BLA hypertrophy (VK55). Chronically elevated cortisol from EMF should produce measurable amygdala enlargement. Test: MRI volumetric analysis in high-EMF occupational workers vs matched controls. Prediction: amygdala volume is significantly larger in high-EMF group.

Old Order Amish (no electricity) → Conservative Amish (some electricity) → Mennonite (modern electricity) → general population. Test: compare chronic disease rates across this cultural gradient. Prediction: disease rates increase monotonically with EMF exposure level, even after controlling for diet, exercise, and lifestyle factors.

Amish dairy farms have minimal EMF. If EMF affects bovine reproduction through the same Ca²⁺ mechanisms, Amish-farm cows should show better fertility. Test: compare conception rates, services per conception, hormone profiles in Amish vs modern dairy. Prediction: Amish-farm cows have significantly better fertility despite same breeds.

Modern water treatment removes trace lithium. Areas that switched to advanced filtration should show increased dementia/suicide rates after the switch. Test: before-after analysis of water treatment upgrades and neuropsychiatric outcomes. Prediction: advanced filtration introduction correlates with subsequent increase in dementia and suicide rates.

Expose Leydig cell cultures to standardized EMF (ELF-modulated RF). Measure testosterone under three conditions: (1) Control, (2) + nifedipine (L-type blocker) isolates T-type contribution, (3) + ethosuximide (T-type blocker) isolates L-type contribution. Prediction: ethosuximide abolishes MORE of the EMF effect than nifedipine.

Expose Leydig cells to: (1) CW at 900 MHz, (2) same carrier amplitude-modulated at 16 Hz (Adey frequency), (3) same carrier modulated at 217 Hz (GSM). Same time-averaged SAR. Prediction: modulated signals produce LARGER effects because the ELF modulation envelope passes through membrane capacitance while the carrier does not.

Replicate Blackman's calcium efflux experiment with ALL five parameters controlled: (1) temperature 36.5±0.3°C stable, (2) blue-rich lighting documented, (3) DC field measured and oriented, (4) Faraday-shielded controls, (5) tissue developmental history documented. Prediction: results are consistent across laboratories when all five parameters match.

Expose pancreatic β-cell lines to standardized EMF at three glucose concentrations (2.8 mM basal, 11 mM stimulatory, 25 mM supramaximal). Prediction: EMF effect is LARGEST at 11 mM (VGCCs maximally primed) and SMALLEST at 2.8 mM (VGCCs mostly closed). Tests the glucose-dependent χ prediction.

RF-EMF exposure in rats with simultaneous measurement of: (1) BTB permeability (FITC-dextran tracer), (2) sperm concentration and motility, (3) tight junction protein expression (occludin, ZO-1). Time-series: 1, 4, 8, 12 weeks. Prediction: BTB permeability increases BEFORE sperm parameters decline (barrier damage precedes toxicity) and decline ACCELERATES over time (positive feedback).

Meta-analysis: compile EMF exposure thresholds across species (insects, birds, rodents, primates) and test whether threshold ∝ body_mass^(0.25). If the metabolic χ scaling is correct, smaller species show effects at lower exposure levels following Kleiber’s law.

Prenatal EMF exposure correlates with shorter anogenital distance (AGD) in newborn boys. Test: measure AGD in birth cohorts with documented maternal EMF exposure. Control for phthalates, BMI, smoking. If negative, prenatal channels 1-3 are weak.

CACNA1C risk variant carriers with high prenatal EMF show higher rates of ASD+gender-atypical development than non-carriers with same exposure. GxE interaction test.

Puberty trends motivate a prospective test, rather than verify an EMF mechanism. Measure personal field dose, screen light and timing, sleep, nutritional and chemical exposures, and baseline developmental state separately. Test whether a preregistered dose × developmental-history interaction predicts timing beyond these covariates.

Salivary oxytocin levels in adolescents inversely correlate with personal EMF exposure (phone use hours). Test: biomarker study with dosimetry.

Insular cortex activation patterns during interoceptive tasks differ between high-EMF and low-EMF adolescents. Test: fMRI with heartbeat detection task.

Gender clinic referral rates correlate with technology adoption timeline across countries. VERIFIED: Sweden +19,700%, Australia +12,650%, UK +2,457%. AFAB majority. Temporal correlation with smartphone adoption ~2010.

Body dysmorphic disorder (BDD) prevalence increases with screen time/device use. VERIFIED: BDD prevalence rising, 'Snapchat dysmorphia' documented.

Compare myopia progression in children with identical outdoor time but different EMF exposure (Faraday-shielded vs standard outdoor areas). If EMF reduction adds to light's protective effect, it confirms the VGCC/DA channel.

Measure NFAT nuclear translocation in T-cells from high-EMF vs low-EMF populations matched for other factors.

Control for volume level. Prediction: EMF component (Bluetooth RF) adds to acoustic damage via Cav1.3 excitotoxicity.

GxE interaction: T-type variant × EMF exposure → more cortical spreading depression events → more migraines.

Measure EEG sleep spindles in subjects with/without evening screen use. Prediction: spindle density ↓ in high-EMF group due to Cav3.3 nRt perturbation.

Cross-national analysis. Prediction: positive correlation because 4 Modulome organs (pancreas, theca, granulosa, pituitary) converge on PCOS pathophysiology.

Expose rats to chronic EMF, measure pain thresholds, then administer selective Cav3.2 blocker. Prediction: blocker reverses EMF-induced hyperalgesia.

EKG screening study with EMF dosimetry. Prediction: chronic EMF → Cav1.2 window current ↑ → action potential prolongation → measurable QTc increase.

The FDA label provides a protocol constraint through its calcium-channel-blocker contraindication; it is not a completed causal co-administration experiment. Prediction: a preregistered blocker experiment should show whether a T-type blocker abolishes the anti-HCC response more strongly than a matched L-type blocker.

In a single cohort, measure: HRV (cardiac Cav3), sleep spindle density (Cav3.3), pain threshold (Cav3.2 DRG), melatonin (CRY/Cav), sperm quality (Cav3 Leydig). Prediction: all should correlate within individuals because all share VGCC/Ca²⁺ as upstream cause.

Based on testosterone threshold model: USA cumulative T loss reaches ~40% around 2030. Prediction: TFR will begin accelerating decline after 2028, dropping below 1.30 by 2035. Falsification: USA TFR remains above 1.40 in 2035.

Finland is already past the biological threshold. Current trajectory: 1.87 (2010) → 1.25 (2024), −2.8%/year (compound). Projection: 1.25 × 0.972^8 ≈ 1.00 by 2032. Falsification: Finland TFR stabilizes above 1.10.

Israel's cultural buffer has maintained TFR ~3.0 despite T decline comparable to USA. Prediction: biological threshold (~40% cumulative loss) reached ~2035, at which point even religiously motivated couples will experience subfertility. Falsification: Israel TFR remains above 2.8 in 2040.

Korea is past the biological threshold (~49% cumulative T loss). Social incentives cannot compensate for biological incapacity. Prediction: TFR stays below 1.0 through 2035 regardless of policy spending. Falsification: Korea TFR rises above 1.0 sustained for 3+ years.

Cross-national regression: T decline rate (age-independent secular trend) predicts TFR change better than GDP, education, or urbanization alone. Testable with existing data from USA, Denmark, Finland, Israel and pending Asian studies. Falsification: GDP or education explain >80% of TFR variance after controlling for T decline.

Formal mediation analysis (Baron & Kenny or SEM) on longitudinal T data with concurrent BMI: indirect effect via BMI = 25–40% of total effect. Based on Mazur 2013 ↗iIs Rising Obesity Causing a Secular (Age-Independent) Decline in Testosterone among American Men?PLoS ONE · 2013 · journalMetadata matched quantification (117/175 ng/dL = 67% direct). Falsification: mediation analysis shows <10% or >60% indirect effect via BMI.

If EMF drives both T decline and BMI increase, then men in EMF-shielded environments should show attenuation of BOTH trends. Testable in occupational cohorts (submarine crews, shielded facilities). Falsification: shielded cohort shows same T decline rate as unshielded.

Santi 2025 ↗iTemporal trends in serum testosterone and luteinizing hormone levels indicate an ongoing resetting of hypothalamic-pituitary-gonadal function in healthy men: a systematic reviewJournal of Endocrinological Investigation · 2025 · journalMetadata matched found global LH decline. BERM predicts this is Route B/D mediated. Countries with higher EMF-proxy (residential electricity, broadband penetration) should show steeper LH decline. Testable with country-level LH data + EMF-proxy. Falsification: no correlation between EMF-proxy and LH decline rate.

Within CAPED database: Amish communities closer to cities (higher ambient EMF) should have lower TFR than remote Amish communities, controlling for sect strictness and community size.

AGD measurement in Tsimane Health and Life History Project cohort vs. urban Trinidadian comparison group. Same geographic region, different EMF exposure. If Tsimane AGD > Trinidad AGD, supports prenatal EMF → masculinization↓.

Already partially confirmed (dementia, brain atrophy). Predict the same gradient for: fertility, metabolic syndrome, autoimmune markers, myopia, sleep quality. This gradient within a genetically matched population is the strongest available natural experiment.

Longitudinal tracking of communities transitioning from no-phone to smartphone use. Predict: sleep quality↓, myopia↑, metabolic markers↑, fertility intention unchanged but biological fertility markers (hormones, sperm) ↓.

Male labor force participation rate will continue declining in every G20 country through 2030, absent a major policy intervention (e.g. universal basic income, mandatory employment programs). The dual lock predicts that population-wide testosterone decline reduces status motivation while cortisol elevation makes workplace competition aversive — producing progressive 'opting out' behavior.

Cross-country analysis will show a significant correlation between smartphone adoption timing (year when penetration exceeded 50%) and the onset of rising sexlessness rates among 18–30 year old males. Countries with earlier smartphone adoption (e.g. South Korea, Japan) should show earlier onset of sexlessness trends than later-adopting countries.

Amish and Mennonite communities — which maintain low personal EMF exposure due to restricted technology use — will show stable or rising marriage rates during 2020–2030, while US national marriage rates continue declining. This tests the dual lock's prediction that the behavioral effects (reduced approach behavior, increased avoidance) are biologically mediated, not purely cultural.

Pre-expose neuronal cultures to 50 Hz ELF for 10 days (priming). Then expose to standardized RF (e.g. 2.4 GHz WiFi). Prediction: primed cells show 2–3× larger Ca²⁺ response to identical RF stimulus compared to unprimed controls. The mechanism: ELF upregulates VGCC expression (PMC4757866 ↗iExtremely Low Frequency Electromagnetic Fields Facilitate Vesicle Endocytosis by Increasing Presynaptic Calcium Channel Expression at a Central SynapseScientific Reports · 2016 · journalMetadata matched), making each cell more sensitive to subsequent RF activation. This is the core ELF priming prediction.

Compare RF-induced biomarkers (salivary cortisol, melatonin, HRV) between Old Order Amish (no residential ELF priming) and matched modern controls after identical acute RF exposure. Prediction: Amish show significantly attenuated response because their VGCC expression is at baseline (not upregulated by 50 Hz). This explains why Amish maintain TFR ~6.1 despite occasional RF exposure from neighboring infrastructure.

In a cohort study with personal EMF dosimetry, residential electricity consumption (kWh/month) will predict chronic EMF biomarkers (melatonin suppression, sperm quality, HRV) more strongly than mobile phone usage hours. The mechanism: electricity measures the ELF priming state, which amplifies ALL subsequent exposures. Mobile phone measures only one RF source. This explains the cross-sectional finding (full-model RMSE 0.522 vs 1.053).

Expose cells to: (1) 50 Hz alone, (2) 2.4 GHz alone, (3) 50 kHz IF alone, (4) all three simultaneously. Measure CaMKII autophosphorylation. Prediction: combined exposure produces CaMKII activation greater than the sum of individual exposures, because different frequencies activate different VGCC subtypes but CaMKII integrates total Ca²⁺ regardless of source.

Expose matched cell groups to identical total EMF dose: (A) continuous multi-band (simulating modern home: 50 Hz + WiFi + LED), (B) same dose but with 8-hour nightly gap (Faraday-shielded sleep period). Prediction: group B shows significantly less cumulative CaMKII activation and less oxidative damage after 30 days, because the recovery window allows Ca²⁺ homeostasis restoration. This tests whether the 24/7 nature of modern exposure — not just the dose — drives the cumulative effect.

WiFi routers emit a 10 Hz beacon pulse even when no data is transmitted (Schmid 2012). The beacon's crest factor is 100:1 — peak power is 100× higher than average (Schmid 2020). Prediction: an isolated 10 Hz pulsed signal at WiFi beacon intensity produces ELF-type biological effects (melatonin suppression, EEG alpha changes) comparable to a continuous 10 Hz sinusoidal field, despite SAR being negligible. This tests whether SAR systematically underestimates WiFi exposure by measuring average instead of peak.

The EU Directive 244/2009 ↗iCommission Regulation (EC) No 244/20092009 · regulatoryMetadata matched forced incandescent ban between 2009–2012, mandatory LED adoption. Prediction: EU countries show a statistically significant acceleration in sperm quality decline starting 2012–2015 compared to countries that adopted LED lighting later (e.g. some Asian, African countries). This tests whether the IF channel (20–300 kHz LED driver frequencies) contributes independently to reproductive decline beyond the RF channel.

Electric vehicle inverters produce 5–50 kHz IF fields in the cabin. Compare IF-relevant biomarkers (testicular function, HRV during driving) between matched EV and internal combustion engine (ICE) vehicle drivers with equivalent daily commute times. The Israeli patent US12379429 (active field cancellation for EV cabins) demonstrates that industry recognizes in-cabin fields as problematic. Prediction: EV drivers show measurably higher oxidative stress markers and lower HRV during driving compared to ICE drivers.

EU LED mandate 2009–2012 forced IF channel opening. Countries that resisted or delayed LED adoption should show later IF-specific health effects (metabolic, sleep). Testable with country-level LED market share timelines vs health data acceleration points.

If 2012 inflection is DEVICE (EMF) not CONTENT (social media), then banning social media for teens while allowing smartphone use will not reduce depression/anxiety rates. Australia's social media ban (2024) is the direct test. Norway's age verification is a secondary test.

For 20+ developing countries: T2D/obesity onset year correlates more strongly with electrification date (year electricity access exceeded 50%) than with GDP crossing any threshold. China T2D: 1.3% (1980) → 8.7% (2014) parallels electrification 60%→100%, not GDP per se.

Taxi/delivery drivers using EVs 8+ hours/day accumulate IF exposure (inverter 5–50 kHz in cabin). Predicted effects: metabolic, reproductive, cardiac — at higher rates than ICE vehicle drivers matched for sedentary time. Israeli patent US12379429 demonstrates industry awareness.

Tsimane, Hadza, and comparable populations will begin showing RF background exposure from LEO satellite constellations. Their health metrics will begin converging toward industrialized patterns within 10–15 years of exposure onset. IRREVERSIBLE loss of verification capacity.

LED drivers + EV inverters + induction cookers + wireless charging all operate at 20–300 kHz. This is the fastest-growing and least-regulated EMF band. IF-specific health effects (distinct from ELF or RF) will emerge as a recognized category by 2035. TTFields (FDA-approved, 200 kHz) already demonstrates IF bioactivity.

Workers who were remote (high home EMF: WiFi+LED 24h/day, multiple devices, no commute recovery) show greater T2D acceleration than workers who continued commuting (mixed EMF environments with outdoor recovery time). Recovery_deficit is the distinguishing variable, not just sedentary time.

SAD/depression prevalence should correlate with latitude × EMF density interaction, not with latitude as a standalone predictor. High-latitude, low-EMF communities (Amish in northern US, rural Scandinavia pre-electrification) should show lower SAD than predicted by latitude alone.

The health benefit of sleeping in an EMF-free environment (Faraday cage, airplane mode, no WiFi) should be measurably LARGER in winter months at high latitudes, because CRY magnetoreceptor sensitivity is higher when ambient light is reduced.

Populations with higher CACNA1C rs1006737 A-allele frequency show steeper health decline per unit EMF exposure. This predicts population-level variation in EMF sensitivity that is genetic, not cultural.

In controlled EMF exposure studies, individuals with CACNA1C rs1006737 A/A genotype show larger physiological responses (sleep EEG, HRV, calcium markers) than G/G genotype individuals. Already supported by Sousouri 2025 ↗iCACNA1C genotype determines sleep EEG response to 5G exposure in double-blind studyNeuroImage · 2025 · journalMetadata matched (ETH) for 5G sleep response.

Water's dielectric constant (~80 vs air ~1) amplifies electric field conduction. Island nations and coastal populations may show higher EMF-associated health effects per unit exposure than inland populations. Japan (island, highest ASD globally) is consistent but not proof. This applies equally to conventional explanations.

Reinforced concrete reflects RF internally, increasing indoor field strength. Wood is RF-transparent. Occupants of wood buildings should show better sleep, lower stress markers, and better cardiovascular metrics than concrete building occupants, beyond what biofiilia theory predicts.

Removing all EMF sources from the bedroom (WiFi router, phone, LED lights) and sleeping in an EMF-reduced environment should produce measurable melatonin increases within 2 weeks, even without any other lifestyle change.

The previously proposed 4–6-hour interval is an uncalibrated candidate. In a measured exposure/withdrawal protocol, sample receptor state, calcium/CaMKII markers, repair flux, absolute damage and function across multiple pause durations. Fit and test recovery times independently; do not assume negligible recovery before four hours or equate a 20-hour delayed protective effect with a molecular time constant.

CACNA1C is critical for synaptogenesis. Prenatal Ca²⁺ disruption during developmental windows → timing errors → ASD/ADHD phenotype. Kaiser Permanente (Li et al. 2017) already showed prenatal EMF → ASD risk. First trimester should show strongest effect.

The interaction of winter (high CRY sensitivity) and high EMF exposure should produce the worst health outcomes — worse than either factor alone. Nordic countries in winter should show peak EMF sensitivity.

Combined EMF + pesticide exposure produces more severe effects than either alone. The interaction is superadditive because pesticides stress cells → Ca²⁺ dysregulation → EMF sensitivity increases. Lupi 2021iMehiläisten navigaatio ja EMF2021 · reportNo verified source link already demonstrated this in bee biochemical and behavioral markers.

Bumblebee population decline should correlate with local WiFi access point density, independent of pesticide use and habitat loss. New 2025 studyiRF-EMF reduces bumblebee visitation to flowersEnviron Pollut · 2025 · experimentalVerification pending already showed RF reduces bumblebee flower visitation.

Boyes 2021 ↗iStreet lighting has detrimental impacts on local insect populationsScience Advances · 2021 · journalMetadata matched found LED streetlights reduced insect abundance by 52% vs sodium's 41%. The 11% difference is not explained by light spectrum alone — LED's IF emission (from SMPS drivers, 20–300 kHz) adds an EMF exposure channel that sodium lacks.

Migratory birds depend on CRY-based magnetoreception for navigation. RF disrupts CRY. Therefore migratory species should show steeper population decline than resident species in the same habitat, independent of habitat loss.

Bee colonies in Faraday-shielded hives (blocking ambient RF/ELF) should produce measurably more honey, show lower colony loss rates, and demonstrate better navigation (fewer lost foragers) than unshielded hives in the same location.

Frog populations should persist in areas with minimal power grid infrastructure and low RF background, while declining in electrified areas — even controlling for habitat quality, water contamination, and UV exposure. Frogs' moist skin provides direct environmental Ca²⁺ coupling.

Shift workers who sleep in a Faraday-shielded bedroom (EMF-free) show better melatonin recovery and less metabolic syndrome than shift workers sleeping in conventional bedrooms — with the same total sleep time. The difference isolates the EMF component from the sleep deprivation component.

Shift work health effects (metabolic syndrome, depression, cardiovascular risk) should be measurably worse during winter months at high latitudes, because CRY magnetoreceptor sensitivity is higher when ambient light is reduced — amplifying EMF disruption during the critical night shift period.

The metabolic syndrome odds ratio for shift workers (OR 2.17) exceeds what pure sleep deprivation alone would predict. The excess risk is attributable to the EMF component: LED IF exposure during melatonin peak hours and eliminated recovery window.

Indoor workers (office, data center) show higher metabolic syndrome prevalence than outdoor workers (farmers, fishermen) even after matching for physical activity level. The difference is attributable to cumulative EMF exposure differential.

Indoor workers show lower nighttime melatonin levels than outdoor workers even after controlling for light exposure patterns. The residual difference reflects EMF exposure from office WiFi, LED lighting IF, and device proximity.

Men who carry their phone in a breast pocket show better sperm quality than men who carry it in a hip/front pocket — despite the same total usage time. The difference is explained by testes being in the near-field only for hip pocket users.

The doubling of sperm decline rate (1.16%→2.64%/yr after 2000) correlates with 3G/4G data adoption (phone stays in pocket continuously) rather than 2G voice call adoption (phone held to ear during calls only). This is a behavioral exposure change, not a technology power change.

50 Hz (Europe) is within 2 Hz of the 8th Schumann resonance harmonic (52.0 Hz), potentially producing stronger CRY interference. European populations may show slightly stronger CRY-dependent cascade effects (melatonin suppression, depression) than American populations at matched total EMF levels.

A retrospective analysis of 50–100 published EMF bio-assay studies, coding for study month, laboratory latitude, building material, and subject background, will show that these four moderators significantly predict whether a study found a positive or null result. This is testable WITHOUT new data.

Winter + CACNA1C-genotyped + low lab-ELF + EMF-free sleep + chronic + pulsed + real device = positive result in EVERY lab.

Most specific single prediction combining 3 moderators: genotype + season + exposure.

Ivancsits showed 9h recovery. Subjects sleeping EMF-free show lower comet tail factor than subjects sleeping with WiFi.

rs10830963 G-allele → more MT2 receptors → β-cells hypersensitive to melatonin changes. EMF-induced melatonin suppression differentially affects GG carriers. The gene × EMF interaction is SUPERADDITIVE: EMF 'activates' the genetic risk that would be latent in a normal melatonin environment.

CRY1Δ11 (rs184039278, 0.6% frequency) lengthens the circadian period. EMF disrupts CRY → the effects are ADDITIVE: genetic lengthening + EMF disruption = longer sleep latency, shorter recovery window, and worse metabolic outcomes.

Val/Val = fast dopamine clearance = low DA baseline. EMF-induced dopamine synthesis reduction hits harder (smaller buffer). Met/Met has a higher baseline DA buffer → more resilient to EMF-induced DA reduction.

Cav1.3 GoF → inner ear hypersensitivity. Bluetooth earphones activate Cav1.3 in hair cells → Ca²⁺ overload. GoF carriers reach damage threshold at lower exposure levels → tinnitus earlier.

Both conditions arise from the same melatonin suppression pathway acting in different organs (brain vs. pancreas). Compound carriers of CACNA1C rs1006737 AA (more Ca²⁺ influx → more melatonin suppression) and MTNR1B rs10830963 GG (β-cells hypersensitive to melatonin) should show the highest comorbidity rate.

CRY1Δ11 delays melatonin offset → morning melatonin still elevated. MTNR1B GG → β-cells hypersensitive to this elevated morning melatonin → insulin suppression specifically in the morning → fasting glucose elevated.

EHS is a polygenic calcium threshold disorder: high influx (CACNA GoF) + slow extrusion (SLC8A1/ATP2B LoF) = Ca²⁺ accumulates → CaMKII threshold crossed at lower EMF. Genotyping EHS cohorts for these 15 genes will show enrichment of high-influx/slow-extrusion combinations.

Combining CACNA1C, CACNA1H, CACNA1D, CACNA1A, CACNA1B, CACNA2D1, CAMK2A, CAMK2B, SLC8A1, ATP2B1, ATP2B2, CRY1, CRY2, MTNR1B, and COMT into a single PRS should predict the magnitude of biological response to standardized EMF exposure.

Genetic risk (MTNR1B GG T2D risk ~1.5×) × EMF risk (~1.3×) produces observed risk ~2.5× (> 1.5 × 1.3 = 1.95×). EMF 'activates' genetic risks that would be latent in EMF-free environments. Testable via biobank stratification by residential EMF exposure.

Pregabalin/gabapentin bind α2δ-1 → block VGCC trafficking to synapses → lower synaptic VGCC density → reduced ELF priming effect. Gabapentinoid users should show attenuated biological responses to EMF exposure compared to matched non-users.

CaMKII autophosphorylation at Thr286 is measurable in peripheral lymphocytes. Higher baseline autophosphorylation = closer to threshold = more sensitive to EMF. This could be the first OBJECTIVE biomarker for EHS.

CACNA2D1 encodes α2δ-1, the bottleneck for VGCC trafficking. Individuals with higher baseline α2δ-1 expression should show faster VGCC density increase under ELF exposure (faster priming).

If α2δ-1 is the molecular mediator of ELF priming (PMC4757866 ↗iExtremely Low Frequency Electromagnetic Fields Facilitate Vesicle Endocytosis by Increasing Presynaptic Calcium Channel Expression at a Central SynapseScientific Reports · 2016 · journalMetadata matched), then pregabalin (which binds α2δ-1) should prevent the VGCC density increase observed after 8-10 days of 50/60 Hz exposure.

CAMK2A GoF mutations that increase Thr286 autophosphorylation produce epilepsy, intellectual disability, and autism (Küry 2017 ↗iDe Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability.American journal of human genetics · 2017 · journalMetadata matched). BERM predicts EMF increases population-level autophosphorylation → same phenotypes at population level. Genetic validation of the mechanism.

Urban residents (higher cumulative EMF) should show higher baseline CaMKII Thr286 autophosphorylation in peripheral lymphocytes than rural controls matched for age, diet, and activity.

Korean 2025 study ↗iPolymorphisms in CACNA1A, CACNA1C, and CACNA1H Genes in Korean Pediatric Patients with Developmental Delay and Intellectual Disability: A Focus on Epilepsy ComorbidityGenes · 2025 · journalMetadata matched showed CACNA1A + CACNA1C + CACNA1H polymorphisms interact in pediatric DD/epilepsy. BERM predicts this extends to all 5 influx genes: compound carriers of multiple CACNA risk alleles show disproportionately higher neurodevelopmental risk.

The current grand solar minimum (2020–2053) will NOT produce a cultural renaissance comparable to previous grand minima (Italian Renaissance/Spörer, Scientific Revolution/Maunder, Romanticism/Dalton) because anthropogenic electromagnetic infrastructure masks the biological recovery that solar minima previously enabled.

As Sub-Saharan Africa’s mobile network penetration crosses 80% and grid electrification exceeds 60%, regional TFR will begin declining at a rate comparable to East Asia’s 1990–2010 trajectory (>0.1/year), despite strong pronatalist cultural norms.

No national pronatalist policy will achieve sustained (>5 year) return to replacement-level fertility (TFR ≥ 2.1) in any country with mobile penetration >90% and grid coverage >95%, regardless of spending level.

Communities that restrict electromagnetic technology (Old Order Amish, ultra-Orthodox with kosher phones, technology-free intentional communities) will maintain TFR >4.0 while surrounding populations continue declining, and communities that adopt technology will see TFR converge toward mainstream within one generation (~25 years).

The electromagnetic species gradient (r=0.84) will persist: species with less EM exposure maintain higher fertility, and domesticated animals in high-EMF environments continue declining alongside humans. Specifically, dog sperm quality will continue declining in parallel with human sperm quality in urbanized regions.

Low-EMF populations maintain higher biological activation. Sub-Saharan African males (lower cumulative EMF exposure from lower electrification, mobile penetration, and urbanization rates) should show higher mean serum testosterone than age-, BMI-, and activity-matched European males. This is the population-level prediction from the hormetic framework: the recovery term α dominates in low-EM environments.

Immigrants from low-EMF countries (sub-Saharan Africa, rural South Asia) to high-EMF countries (Western Europe, East Asia) should show measurable biomarker convergence toward host-country values within 15–25 years. Specifically: testosterone decline, cortisol increase, melatonin decrease, sperm quality decline — independent of dietary and lifestyle acculturation. The EMF environment is the unexplained residual after controlling for behavioral adaptation.

Old Order Amish (no grid electricity, no personal electronics) provide a within-country control for EMF exposure. Prediction: Amish males show higher serum testosterone, lower cortisol, higher melatonin, and better sperm parameters than age- and BMI-matched mainstream American males. This is the most directly testable activation prediction because it controls for nationality, healthcare access, and genetic background.

Regions with high geomagnetic storm exposure AND dense power grid infrastructure will show elevated cardiovascular event rates (MI, stroke) during strong geomagnetic storms (Kp ≥ 7), compared to: (a) same regions during quiet conditions, and (b) high-storm regions with sparse grids. The effect should be strongest at high magnetic latitudes (>55°) where GIC amplitudes are largest. Predicted effect size: 5–15% increase in daily MI rate during severe storms in grid-dense high-latitude regions.

Urban populations where Schumann resonance (7.83 Hz) is measurably masked by anthropogenic ELF noise will show higher rates of circadian disruption markers (delayed sleep phase, melatonin onset delay, cortisol rhythm flattening) compared to rural populations where SR signal is clean, after controlling for light exposure, work schedules, and socioeconomic factors. Measurement: SR signal-to-noise ratio at bedroom level should inversely correlate with circadian rhythm quality (r > 0.3, p < 0.01).

If ISS astronauts are provided with a local 25–50 μT static magnetic field (simulating Earth-surface geomagnetic conditions) during sleep periods, their melatonin onset will normalize toward ground-based values (currently delayed 2.7–3.0 hours), sleep duration will increase toward 7+ hours (currently 6.4 hours), and circadian phase markers will stabilize. This directly tests whether the hypomagnetic environment — not microgravity alone — drives the CRY-mediated circadian disruption observed in spaceflight.